Digoxin and Alginate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Alginate (algin). Common drug interactions include tinnitus among females and atrial tachycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Alginate. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Alginate?

Alginate has active ingredients of algin. eHealthMe is studying from 1,556 Alginate users. Check the latest studies of Alginate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

18 people who take Digoxin and Alginate together, and have interactions are studied.

What are the common drug interactions of Digoxin and Alginate, by gender? *:

female:

Tinnitus (a ringing in the ears)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Vasculitis (inflammation of a blood vessel or blood vessels)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Visual impairment
Vomiting
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Disease recurrence
Gastric mucosal lesion (lesion of stomach mucous membrane)
Neutropenia (an abnormally low number of neutrophils)

male:

Atrial tachycardia (rhythm disturbance that arises in the atria)
Syncope (loss of consciousness with an inability to maintain postural tone)
Blood alkaline phosphatase increased
Cardiac failure acute
Conjunctivitis (pink eye)
Hallucination (an experience involving the perception of something not present)
Hyperthermia (body temperature greatly above normal)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Left ventricular dysfunction
Blood uric acid increased

What are the common drug interactions of Digoxin and Alginate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Disease recurrence
Gastric mucosal lesion (lesion of stomach mucous membrane)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Neutropenia (an abnormally low number of neutrophils)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Lung disorder (lung disease)
Skin lesion
Syncope (loss of consciousness with an inability to maintain postural tone)
Thrombocytopenia (decrease of platelets in blood)
Blood uric acid increased
Cardiac disorder
Ear haemorrhage (bleeding from ear)
Gastric cancer (stomach cancer)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 4 people, 22.22%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 16.67%
Allergies: 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
Diarrhea: 3 people, 16.67%
Hyperkalemia (damage to or disease of the kidney): 2 people, 11.11%
Pain: 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 11.11%
Infection: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Alginate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously